StreetAlpha.app
Home › Stocks › FOCL

Edap Tms SA (FOCL)

$2.84
▼ −10.41%
LAST CLOSE · NOV 17

EDAP TMS makes the Focal One robotic HIFU system, which uses focused ultrasound to treat prostate tissue, and sells it to urologists. It last closed at $2.84 on Nov 17, down 10.41% on the day.

AI Auto Pilots
Is FOCL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$81.3M
Net income
−$37.5M
−46.1% margin
EPS (diluted)
−$0.96
Gross margin
45.1%
$36.7M gross profit
Valuation
Market cap
$134.1M
47.2M shares
P/E
–
No P/E while losing money
Price to sales
1.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$56.3M
At Sep 30
Debt
$35.6M
At Sep 30
Shareholder equity
$35.9M
Shares outstanding
47.2M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $69.4M$69.4MFY2024FY2025: $70.5M$70.5MFY2025

From FOCL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated FOCL in the past 90 days, not enough for a consensus
Average 12-month target
$10.00
▲ 252.1% upside

Based on 1 analyst who set a price target on FOCL in the past 90 days. The average target is $10.00, with a high of $10.00 and a low of $10.00, compared with the last close of $2.84.

Low $10.00Avg $10.00High $10.00
Blue marker: last close $2.84
Highest target$10.00
Average target$10.00
Lowest target$10.00
Latest rating changes
HC Wainwright & Co.Reiterated
Aug 25Buy$10
HC Wainwright & Co.Reiterated
Jun 2Buy$10
DateFirmActionRatingPrice target
Aug 25HC Wainwright & Co.ReiteratedBuy$10
Jun 2HC Wainwright & Co.ReiteratedBuy$10
Loading…

Technical Analysis

FOCL · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 36% below its 20 day and 44% below its 50 day average. It is 54% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot S1 at $2.72, and the nearest resistance the Pivot at $2.92.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 10.5%/day
Key levels
$6.4052 week high+125.4%
$4.65100 day average+63.7%
$4.39200 day average+54.6%
$4.30Swing high (Sep 10)+51.4%
$4.1050 day average+44.4%
$3.8620 day average+35.9%
$3.04Pivot R1+7.0%
$2.92Pivot+2.8%
$2.84Last close
$2.72Pivot S1−4.2%
$1.9552 week low−31.3%
Indicators
RSI (14)25.01Oversold below 30Oversold
MACD-0.30Below its signal lineBearish
Stochastic1.2Near the bottom of its rangeOversold
ADX (14)36.1Trending down
Williams %R-97.6Oversold below −80, overbought above −20Oversold
CCI (20)-163.4Oversold below −100, overbought above 100Oversold
Rate of change−32.4%Change over 10 sessionsBearish
ATR (14)$0.30Typical daily range, 10.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for FOCL

What happened before

See how FOCL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow FOCL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How FOCL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in FOCL in the last 90 days.

Loading…

See today’s whale options flow across the market →

FOCL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲32 buying vs 5 selling
  • ▲Held by funds +10.8 pts
  • ▲Funds holding +13
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding5037+35.1%
In funds' top 1000–
Held by funds43.8%33.0%+10.8 pts
New / increased17 / 156 / 9+113.3%
Reduced / sold out3 / 25 / 5−50.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FOCL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FOCL is in one of them and how their past FOCL trades turned out.

FOCL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FOCL in an article yet. Here's the latest on the wider market.

About Edap Tms SA

EDAP TMS is a medical device company based in Vaulx-en-Velin, France. Its main product is the Focal One robotic HIFU system, which uses focused ultrasound to treat prostate tissue, mainly for prostate cancer. The company sells the system to urologists and other healthcare providers. It also sells older urology products, such as lithotripsy systems, and distributes some third-party urology equipment along with related services.

Headquarters
69120 Vaulx En Velin, France